Lévy P - Search Results

1

Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.

Porte F, Granghaud A, Chang J, Kearney M, Morel A, Plessala I, Cawston H, Roiz J, Xiao Y, Solbes MN, Lambert P, Ravaud A, Loriot Y, Thiery-Vuillemin A, Lévy P. Porte F, et al. Among authors: levy p. PLoS One. 2024 May 10;19(5):e0302548. doi: 10.1371/journal.pone.0302548. eCollection 2024. PLoS One. 2024. PMID: 38728337 Free PMC article.

2

Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.

Druais S, Doutriaux A, Cognet M, Godet A, Lançon C, Levy P, Samalin L, Guillon P. Druais S, et al. Among authors: levy p. Pharmacoeconomics. 2016 Apr;34(4):363-91. doi: 10.1007/s40273-015-0348-x. Pharmacoeconomics. 2016. PMID: 26883132 Free PMC article.

3

Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.

Paix A, Noel G, Falcoz PE, Levy P. Paix A, et al. Among authors: levy p. Radiother Oncol. 2018 Sep;128(3):534-540. doi: 10.1016/j.radonc.2018.04.013. Epub 2018 Apr 26. Radiother Oncol. 2018. PMID: 29706462

4

Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France.

Chouaid C, Bensimon L, Clay E, Millier A, Levy-Bachelot L, Huang M, Levy P. Chouaid C, et al. Among authors: levy bachelot l, levy p. Lung Cancer. 2019 Jan;127:44-52. doi: 10.1016/j.lungcan.2018.11.008. Epub 2018 Nov 23. Lung Cancer. 2019. PMID: 30642550 Free article.

5

Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease.

Cowie MR, Lamy A, Levy P, Mealing S, Millier A, Mernagh P, Cristeau O, Bowrin K, Briere JB. Cowie MR, et al. Among authors: levy p. Cardiovasc Res. 2020 Sep 1;116(11):1918-1924. doi: 10.1093/cvr/cvz278. Cardiovasc Res. 2020. PMID: 31807773 Free PMC article.

6

Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.

Bowrin K, Briere JB, Fauchier L, Coleman C, Millier A, Toumi M, Clay E, Levy P. Bowrin K, et al. Among authors: levy p. PLoS One. 2020 Jan 24;15(1):e0225301. doi: 10.1371/journal.pone.0225301. eCollection 2020. PLoS One. 2020. PMID: 31978044 Free PMC article.

7

[Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study].

Levy E, Levy P. Levy E, et al. Among authors: levy p. Rev Epidemiol Sante Publique. 1992;40(5):285-95. Rev Epidemiol Sante Publique. 1992. PMID: 1480805 French.

8

[Economic evaluation of the contribution of captopril in the treatment of diabetic nephropathy:a cost-benefit approach].

Le Pen C, Petitjean P, Lévy P, Hannedouche T. Le Pen C, et al. Among authors: levy p. Nephrologie. 1996;17(6):321-6. Nephrologie. 1996. PMID: 8975150 Review. French.

9

A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.

Levy P, Lechat P, Leizorovicz A, Levy E. Levy P, et al. Among authors: levy e. Cardiovasc Drugs Ther. 1998 Jul;12(3):301-5. doi: 10.1023/a:1007773901631. Cardiovasc Drugs Ther. 1998. PMID: 9784910 Clinical Trial.

10

Pharmacoeconomic evaluation of medical treatment of epilepsy: where do we stand?

Levy P. Levy P. Acta Neurol Belg. 1999 Dec;99(4):239-46. Acta Neurol Belg. 1999. PMID: 10674141 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,978 results

Search Page

Filters